Pyridoxal-5(')-phosphate oxidase (PNPO) deficiency presents as a severe neonatal encephalopathy responsive to pyridoxal-5(')-phosphate (PLP) or pyridoxine. Recent studies widened the phenotype of this condition and detected genetic variants on PNPO gene whose pathogenic role and clinical expression remain to be established.

Pyridoxine-5'-phosphate oxidase (pnpo) deficiency. clinical and biochemical alterations associated with the c.347g>a (pp. arg116gln) mutation / Di Salvo, Martino Luigi; Mastrangelo, Mario; Nogués, Isabel; Tolve, Manuela; Paiardini, Alessandro; Carducci, Carla; Mei, Davide; Montomoli, Martino; Tramonti, Angela; Guerrini, Renzo; Contestabile, Roberto; Leuzzi, Vincenzo. - In: MOLECULAR GENETICS AND METABOLISM. - ISSN 1096-7192. - (2017), pp. 1-8. [10.1016/j.ymgme.2017.08.003]

Pyridoxine-5'-phosphate oxidase (pnpo) deficiency. clinical and biochemical alterations associated with the c.347g>a (pp. arg116gln) mutation

DI SALVO, Martino Luigi;MASTRANGELO, Mario;TOLVE, MANUELA;PAIARDINI, ALESSANDRO;CARDUCCI, Carla;TRAMONTI, Angela;CONTESTABILE, Roberto;LEUZZI, Vincenzo
2017

Abstract

Pyridoxal-5(')-phosphate oxidase (PNPO) deficiency presents as a severe neonatal encephalopathy responsive to pyridoxal-5(')-phosphate (PLP) or pyridoxine. Recent studies widened the phenotype of this condition and detected genetic variants on PNPO gene whose pathogenic role and clinical expression remain to be established.
2017
children; epilepsy; pyridoxal-5′-phosphate; pyridoxal-5′-phosphate oxidase deficiency; vitamin b(6); vitamin dependent epilepsies
01 Pubblicazione su rivista::01a Articolo in rivista
Pyridoxine-5'-phosphate oxidase (pnpo) deficiency. clinical and biochemical alterations associated with the c.347g>a (pp. arg116gln) mutation / Di Salvo, Martino Luigi; Mastrangelo, Mario; Nogués, Isabel; Tolve, Manuela; Paiardini, Alessandro; Carducci, Carla; Mei, Davide; Montomoli, Martino; Tramonti, Angela; Guerrini, Renzo; Contestabile, Roberto; Leuzzi, Vincenzo. - In: MOLECULAR GENETICS AND METABOLISM. - ISSN 1096-7192. - (2017), pp. 1-8. [10.1016/j.ymgme.2017.08.003]
File allegati a questo prodotto
File Dimensione Formato  
di Salvo_Pyridoxine-5′-phosphate_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 3.41 MB
Formato Adobe PDF
3.41 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1001903
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 26
social impact